Taking on Monopoly Power: Public Pharma

World Diabetes Day 2025: Advocates stand together for Access, Affordability, and Action

16 Nov 2025, 7:39 p.m. in Action & Workshop, Country: Democratic Republic of Congo, Country: Egypt, Country: France, Country: Global, Country: Nigeria, Country: Pakistan, Country: Sierra Leone, Country: South Africa, Country: United States, Insulin Access: Price Caps, Taking on Monopoly Power: Public Pharma, The Right to Full Care: Combatting Discrimination with Education, The Right to Full Care: Glucose Self-Monitoring Supplies, The Right to Full Care: Other Essential Medicine Access & Universal Health Coverage by T1International

On November 14th, 2025, World Diabetes Day, #insulin4all advocates across the globe came together to make a demand: that they be able to access and afford their life-sustaining medications. Recent data showed that 1 in 3 people around the world rationed their insulin due to cost in 2024. At T1International, we know that #insulin4all is a reasonable and dignified demand– and yet, we are still too far from achieving a reality where everyone, no matter where they live, has access to the medicine and supplies they need to survive and flourish. Read more

New $55 Insulin Pens Mark Step in California’s Fight Against Insulin Price Gouging

7 Oct 2025, 10:40 p.m. in Content Type: News & Statements, Country: United States, Taking on Monopoly Power: Public Pharma by T1International

The state of California will take significant steps forward to increase insulin access and affordability – beginning January 1, 2026, CalRx will offer a box of five insulin pens for $55 to anyone who needs it. California announced that Civica will contract with India-based biosimilar manufacturer Biocon to fulfill its commitment to bring low-cost insulin glargine (a long-acting and not name-brand insulin) to California through the CalRx label. Read more

Fixing a Broken System: The Path to Public Pharma in New York

6 Oct 2025, 11 p.m. in Action & Workshop, Contains: Resource, Country: United States, Taking on Monopoly Power: Public Pharma by T1International

On Thursday, September 25, 2025, T1International brought policy leaders, advocates, and patients together at NYU Law for “Fixing a Broken System: The Path to Public Pharma in New York,” a major public event highlighting the urgent need for publicly controlled pharmaceutical production to counter skyrocketing drug prices. Read more

Opinion: The insulin crisis is far from over

16 Oct 2024, 6:08 p.m. in Content Type: News & Statements, Country: United States, Taking on Monopoly Power: Public Pharma by Arden Parrish

This blog post was first published in the Hartford Courant on September 15, 2024 by Arden Parrish under the title: Opinion: The insulin crisis is far from over. Public pharma could be the solution. Read more

The movement for public insulin production continues to grow in the United States

12 Jun 2024, 7:40 p.m. in Content Type: News & Statements, Country: United States, Taking on Monopoly Power: Public Pharma by Quinn Nichols, Nicole Koonce, and Allison Hardt

This blog post was first published in Bridge Michigan on May 28, 2024 by Quinn Nichols, Nicole Koonce, and Allison Hardt under the title: Michigan has a chance to learn from California’s public pharma initiative. Read more

Insulin Shortages: a policy choice with policy solutions

8 May 2024, 4:38 p.m. in Content Type: Advocacy Stories, Country: Pakistan, Country: United States, Taking on Monopoly Power: Public Pharma by Shaina Kasper, Policy & Advocacy Director, T1International

Over the past few months, people with type 1 diabetes around the globe have been going from pharmacy to pharmacy in search of insulin. There have been insulin shortages in many different countries. For people living with type 1 diabetes, insulin is as important as oxygen and people need a consistent supply. Insulin shortages can lead to irreversible complications and even death. Read more

Global Day of Action for #insulin4all demands insulin equity NOW

21 Mar 2024, 3:50 p.m. in Action & Workshop, Country: France, Country: India, Country: Pakistan, Country: Tanzania, Country: United States, Country: Zimbabwe, Insulin Access: Price Caps, Taking on Monopoly Power: Public Pharma, The Right to Full Care: Combatting Discrimination with Education by T1International

On March 16, 2024, hundreds of #insulin4all advocates participated in over a dozen events across the globe calling for insulin access and affordability as part of the Global Day of Action for #insulin4all, sharing their stories on the critical need for insulin equity now. Read more

Three Reasons Why is Insulin STILL So Expensive

29 Aug 2023, 4:49 p.m. in Contains: Resource, Country: Global, Insulin Access: Alec's Law, Insulin Access: Kevin's Law, Insulin Access: Modern Insulins, Insulin Access: Price Caps, Taking on Monopoly Power: Patent Reform, Taking on Monopoly Power: Public Pharma by Shaina Kasper

Over the past few months, many insulin manufacturers and other entities have announced that they will be lowering the price of insulin in the United States. So, why is insulin still so expensive?
We recently released our Policy Playbook that goes through all of the details and gives advocates the information to push for change locally and nationally. Why insulin is so expensive can be boiled down to three main points. Read more